S
AMRX icon

SignatureFD’s Amneal Pharmaceuticals AMRX Stock Holding History

SignatureFD’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.9K Buy
4,269
+1,759
+70% +$24.1K ﹤0.01% 1633
2026
Q1 		$31.2K Buy
2,510
+53
+2% +$712 ﹤0.01% 1989
2025
Q4 		$31K Hold
2,457
– – ﹤0.01% 1919
2025
Q3 		$24.6K Sell
2,457
-260
-10% -$2.33K ﹤0.01% 2017
2025
Q2 		$22K Buy
2,717
+11
+0.4% +$83 ﹤0.01% 2003
2025
Q1 		$22.7K Hold
2,706
– – ﹤0.01% 2002
2024
Q4 		$21.4K Hold
2,706
– – ﹤0.01% 2031
2024
Q3 		$22.5K Sell
2,706
-650
-19% -$5.08K ﹤0.01% 1983
2024
Q2 		$21.3K Hold
3,356
– – ﹤0.01% 1940
2024
Q1 		$20.3K Hold
3,356
– – ﹤0.01% 1988
2023
Q4 		$20.4K Buy
3,356
+8
+0.2% +$36 ﹤0.01% 1910
2023
Q3 		$14.1K Hold
3,348
– – ﹤0.01% 2026
2023
Q2 		$10.4K Buy
3,348
+48
+1% +$102 ﹤0.01% 2221
2023
Q1 		$4.59K Sell
3,300
-1,189
-26% -$2.37K ﹤0.01% 2540
2022
Q4 		$8.93K Sell
4,489
-669
-13% -$1.5K ﹤0.01% 2207
2022
Q3 		$10K Buy
5,158
+1,237
+32% +$3.47K ﹤0.01% 2065
2022
Q2 		$12K Buy
3,921
+633
+19% +$2.29K ﹤0.01% 2018
2022
Q1 		$14K Hold
3,288
– – ﹤0.01% 1990
2021
Q4 		$16K Hold
3,288
– – ﹤0.01% 1870
2021
Q3 		$18K Hold
3,288
– – ﹤0.01% 1794
2021
Q2 		$17K Buy
3,288
+3,000
+1,042% +$17.1K ﹤0.01% 1770
2021
Q1 		$2K Hold
288
– – ﹤0.01% 2432
2020
Q4 		$1K Hold
288
– – ﹤0.01% 2375
2020
Q3 		$1K Hold
288
– – ﹤0.01% 2354
2020
Q2 		$1K Hold
288
– – ﹤0.01% 2254
2020
Q1 		$1K Hold
288
– – ﹤0.01% 2063
2019
Q4 		$1K Buy
+288
New +$1K ﹤0.01% 1983

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

SignatureFD's AMRX Position: Q2 2026 in Review

SignatureFD increased its Amneal Pharmaceuticals (AMRX) stake by 70% in Q2 2026, buying an estimated $24.1K and bringing the position to 4,269 shares worth $73.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

SignatureFD first reported a position in AMRX in Q4 2019 and has held it in 27 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • SignatureFD held 4,269 shares of Amneal Pharmaceuticals worth $73.9K as of Q2 2026.
  • SignatureFD bought 1,759 Amneal Pharmaceuticals shares in Q2 2026, an estimated $24.1K.
  • Amneal Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1633 holding.
  • SignatureFD first reported a position in Amneal Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.